Characterization of MHC Class I and ?-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Characterization of MHC Class I and ?-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.

Haworth KB, Arnold MA, Pierson CR, Leddon JL, Kurmashev DK, Swain HM, Hutzen BJ, Roberts RD, Cripe TP. Characterization of MHC Class I and ?-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials. Pediatr Blood Cancer. 2016 Apr; 63(4):618-26.

View in: PubMed

subject areas

beta 2-Microglobulin
Cell Line, Tumor
Child
Clinical Trials as Topic
Flow Cytometry
Histocompatibility Antigens Class I
Humans
Immunohistochemistry
Immunotherapy
Neoplasms
Oligonucleotide Array Sequence Analysis
Patient Selection
Tissue Array Analysis

authors with profiles

Michael Andrew Arnold

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium